Peptide record

TPDB08149

Antibacterial Anticancer Antifungal Antiparasitic Toxicity standard
16 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08149
Antibacterial Anticancer Antifungal Antiparasitic Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia Antifungipept CAFPdb
standard
No
A 16-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GIMSSLMKKLKKIIAK
Physicochemical Analysis
C81H153N21O19S2
RNDCEQHFPTWYV
K
1789.36
11.12
5
0
8
+5
2.54
0.325
128.12
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
0
0.00
2
Residue Composition
number
1
A
0
R
0
N
0
D
0
C
0
E
0
Q
1
G
0
H
3
I
2
L
5
K
2
M
0
F
0
P
2
S
0
T
0
W
0
Y
0
V
Amino Acid Distribution
A: 1 R: 0 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 1 H: 0 I: 3 L: 2 K: 5 M: 2 F: 0 P: 0 S: 2 T: 0 W: 0 Y: 0 V: 0
Chemical Descriptors
16
C81H153N21O19S2
1789.36
11.12
+5
2.54
0.325
Evidence Records 2 records
Evidence 1 Activity

Activity

50% Hemolysis
Toxicity
>400 µM
Hemolytic Cytotoxic
50% Hemolysis | >400 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Antimicrobial Peptide from the Wild Bee Hylaeus signatus Venom and Its Analogues: Structure-Activity Study and Synergistic Effect with Antibiotics. | J Nat Prod | 2016
Evidence 2 Activity

Activity

LC50
Toxicity
400 µM
Hemolytic
Hemolytic_activity: [Ref.26998557] LC50>400 µM against human red blood cells

Target

erythrocytes

Source & Reference

NA
DRAMP
J Nat Prod. 2016 Apr 22 79(4):1073-83. doi: 10.1021/acs.jnatprod.5b01129.